Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals mixed signals. Basic financial performance shows slight declines in net income and operating income, with increased expenses and reduced cash flow, indicating financial strain. However, management's optimistic guidance for the second half of 2025 and strategic risk mitigation efforts provide a positive outlook. The Q&A session highlights confidence in shipment growth and market expansion, but concerns about underperformance in Asia and unclear management responses add uncertainty. Given the market cap, the stock is likely to experience minor fluctuations, resulting in a neutral sentiment.
Revenue $215 million, up 25% sequentially and 6% year-over-year. The increase was driven by strong sequential growth in both revenue and shipments, reflecting continued progress across the expanding product portfolio.
Shipments $206 million, up 32% sequentially and 2% year-over-year. The growth was attributed to strong sequential rebound in Q2 shipments.
Gross Margin 48.7%, exceeding the target range of 42% to 48%. This was an improvement from 48.2% in the prior year, driven by factors such as sales volume, product mix, and currency impacts.
Operating Expenses $63.4 million, up 38.8% year-over-year. R&D expenses were 14.5% of sales, reflecting increased focus on proprietary R&D programs.
Operating Income $41.5 million, down 20.2% year-over-year. Operating margin was 19.3%, a decrease from 25.6% in the prior year, due to higher operating expenses.
Income Tax Expense $1.9 million, down from $9.3 million in the prior year. The effective tax rate for 2025 is expected to be in the 10% range.
Net Income $36.8 million, slightly down from $37.5 million in the prior year. Net income per diluted share was $0.54, compared to $0.55 in the prior year.
Cash and Cash Equivalents $483.9 million at quarter-end, down from $498.4 million at the end of the first quarter. Net cash was $205.8 million, down from $271.0 million at the end of the first quarter.
Inventory $648.3 million, up from $609.6 million at the end of the first quarter. The increase was due to strategic purchases to support production plans and mitigate potential supply chain risks.
Cash Flow from Operations Used $39.6 million in the first half of 2025, compared to $51.9 million provided in the year-ago period. The change reflects variations in operational cash requirements.
New Ultra C wb wet bench cleaning tool: Integrated ACM patent-pending nitrogen bubbling technology to enhance etching rate uniformity in 3D structures. Received repeat orders and expected good shipments this year and next.
High-temperature SPM tool: Features ACM proprietary nozzle design to improve particle performance and reduce maintenance. Delivered to several customers, gaining market share.
Ultra ECP APP panel-level horizontal plating system: Supports industry shift to panel-level packaging for AI chips. Unique horizontal plating approach delivers superior uniformity.
Track and PECVD platform: Proprietary PECVD platform supports a wide range of processes. Beta tools planned for delivery this year with revenue contribution expected in 2026.
China market revenue target: Increased long-term revenue target for Mainland China to $2.5 billion from $1.5 billion due to updated market size and increased market share targets.
Global revenue target: Raised long-term revenue target to $4 billion from $3 billion, reflecting confidence in global market opportunities.
Lingang production and R&D center: State-of-the-art facility nearly completed, with capacity to support $3 billion of production.
Oregon facility: Upgrades underway for customer demo R&D lab and production capacity, targeting mid-2026 for operations.
Capital raise in China: ACM Shanghai approved to raise up to $620 million to accelerate revenue targets and strengthen market position.
Supply Chain Risk: The company made strategic purchases to support production plans and mitigate potential supply chain risks, indicating concerns about supply chain disruptions.
R&D Investment Pressure: R&D expenses increased to 14.5% of sales, with plans to raise it further to 14%-16% for 2025, which could pressure operating margins.
Operating Margin Decline: Operating margin decreased from 25.6% to 19.3%, reflecting higher operating expenses and potential challenges in cost management.
Inventory Management Challenges: Finished goods inventory increased slightly, and raw materials inventory rose significantly, which could indicate inefficiencies or risks of overstocking.
Geopolitical and Regulatory Risks: The company’s focus on the China market and its proposed capital raise in China could expose it to geopolitical and regulatory uncertainties.
Customer Evaluation Risks: Finished goods inventory includes tools under evaluation at customer sites, which may not convert to sales if evaluations are unsuccessful.
Production Expansion Risks: The company is expanding production facilities in Lingang and Oregon, which involves significant capital expenditures and could face delays or cost overruns.
Market Share and Competition: The company aims to increase market share in cleaning and plating to 60%, but achieving this target may be challenging due to competitive pressures.
Revenue Outlook for 2025: The company is maintaining its 2025 revenue outlook in the range of $850 million to $950 million, implying 15% year-over-year growth at the midpoint.
Long-term Revenue Target: The company has raised its long-term revenue target to $4 billion, up from the previous target of $3 billion. This includes an increase in the long-term revenue target for Mainland China to $2.5 billion (previously $1.5 billion) and maintaining the rest of the world target at $1.5 billion.
Market Share Targets: The company has increased its market share targets for cleaning and plating to 60% (previously 55%) while maintaining targets for furnace, PECVD, and Track at 15% and 10%, respectively.
Product Development and Revenue Contribution: Incremental contributions from Tahoe, SPM, and furnace tools are expected in 2025, with panel-level packaging, Track, and PECVD tools driving growth in 2026 and beyond.
Capital Expenditures for 2025: The company expects to spend about $70 million in capital expenditures for the full year 2025.
Production Facility Expansion: The Lingang production and R&D center is nearly completed, with a combined production capacity of up to $3 billion. The Oregon facility is targeted for demo lab and production operations by mid-2026.
R&D and Operating Expenses: R&D expenses are planned in the 14%-16% range of sales for 2025, reflecting a focus on proprietary R&D programs.
The selected topic was not discussed during the call.
The earnings call reveals several negative aspects: declining operating income and net income, shipment delays due to part shortages, and inventory write-downs impacting margins. Although there is some optimism about future shipments and product innovations, the current financial performance and guidance suggest a negative short-term outlook. The market cap indicates a small-cap stock, which tends to react strongly to such negative news, likely resulting in a -2% to -8% stock price movement.
The earnings call reveals mixed signals. Basic financial performance shows slight declines in net income and operating income, with increased expenses and reduced cash flow, indicating financial strain. However, management's optimistic guidance for the second half of 2025 and strategic risk mitigation efforts provide a positive outlook. The Q&A session highlights confidence in shipment growth and market expansion, but concerns about underperformance in Asia and unclear management responses add uncertainty. Given the market cap, the stock is likely to experience minor fluctuations, resulting in a neutral sentiment.
The earnings call presents a mixed picture. While revenue and market share growth are positive, declining operating income and shipments, coupled with vague management responses, raise concerns. The strong gross margin and cash flow improvements are offset by supply chain and competitive challenges. The market cap suggests moderate sensitivity, leading to a neutral prediction.
The earnings call showed mixed signals: strong revenue growth and gross margin above target are positive, but net income and operating income have declined. The Q&A highlighted management's reluctance to provide clear guidance on shipment growth and tariff impacts, raising concerns. The market strategy and shareholder returns are positive, but competitive pressures and economic factors pose risks. Given the small-cap nature, these factors balance out to a neutral sentiment, with the stock likely to remain stable within a -2% to 2% range over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.